TEQCX
Price
$34.58
Change
-$0.54 (-1.54%)
Updated
Sep 14 closing price
Net Assets
1.46B
VGTSX
Price
$27.61
Change
-$0.35 (-1.25%)
Updated
Sep 14 closing price
Net Assets
665.69B
Interact to see
Advertisement

TEQCX vs VGTSX

TEQCX vs VGTSX Comparison Chart in %
View a ticker or compare two or three
VS
TEQCX vs. VGTSX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEQCX is a Buy and VGTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGTSX has more cash in the bank: 666B vs. TEQCX (1.46B). VGTSX pays higher dividends than TEQCX: VGTSX (2.40) vs TEQCX (0.44). TEQCX was incepted earlier than VGTSX: TEQCX (23 years) vs VGTSX (30 years). TEQCX (2.23) is less costly to investors than VGTSX (0.17). TEQCX is a more actively managed with annual turnover of: 24.00 vs. VGTSX (4.00). VGTSX has a lower initial minimum investment than TEQCX: VGTSX (0) vs TEQCX (2500). VGTSX annual gain was more profitable for investors over the last year : 20.21 vs. TEQCX (15.10). VGTSX return over 5 years is better than : 37.12 vs. TEQCX (24.41).
TEQCXVGTSXTEQCX / VGTSX
Total Expense Ratio1.920.171,129%
Annual Report Gross Expense Ratio2.230.171,312%
Fund Existence23 years30 years-
Gain YTD13.51015.63086%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B666B0%
Annual Yield % from dividends0.442.4018%
Returns for 1 year15.1020.2175%
Returns for 3 years64.2761.28105%
Returns for 5 years24.4137.1266%
Returns for 10 years67.82104.5165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPSX47.99N/A
N/A
ProFunds Biotechnology UltraSector Svc
FKACX27.59N/A
N/A
Franklin Growth Opportunities C
AMCFX45.69-0.20
-0.44%
American Funds AMCAP F-2
IVVYX24.83-0.36
-1.43%
Nomura International Core Equity Y
DRMCX6.39-0.10
-1.54%
Virtus Silvant Mid-Cap Growth Inst